| Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. RHG Falk K, Rötzschke O, Stevanović S, Jung G Nature 351, 290-296, 1991 | 3975 | 1991 |
| SYFPEITHI: database for MHC ligands and peptide motifs HG Rammensee, J Bachmann, NPN Emmerich, OA Bachor, S Stevanović Immunogenetics 50, 213-219, 1999 | 3767 | 1999 |
| MHC ligands and peptide motifs: first listing HG Rammensee, T Friede, S Stevanović Immunogenetics 41, 178-228, 1995 | 2180 | 1995 |
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ... Nature 515 (7528), 577-581, 2014 | 2096 | 2014 |
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival S Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ... Nature medicine 18 (8), 1254-1261, 2012 | 1598 | 2012 |
| Peptides naturally presented by MHC class I molecules HG Rammensee, K Falk, O Rötzschke Annual review of immunology 11 (1), 213-244, 1993 | 1140 | 1993 |
| Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells O Rötzschke, K Falk, K Deres, H Schild, M Norda, J Metzger, G Jung, ... Nature 348 (6298), 252-254, 1990 | 970 | 1990 |
| The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy H Singh-Jasuja, NPN Emmerich, HG Rammensee Cancer Immunology, Immunotherapy 53, 187-195, 2004 | 906 | 2004 |
| Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy H Einsele, E Roosnek, N Rufer, C Sinzger, S Riegler, J Löffler, ... Blood, The Journal of the American Society of Hematology 99 (11), 3916-3922, 2002 | 902 | 2002 |
| In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine K Deres, H Schild, KH Wiesmüller, G Jung, HG Rammensee Nature 342 (6249), 561-564, 1989 | 878 | 1989 |
| Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas J Dengjel, MD Nastke, C Gouttefangeas, G Gitsioudis, O Schoor, ... Clinical cancer research 12 (14), 4163-4170, 2006 | 862 | 2006 |
| Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. UD Staerz, HG Rammensee, JD Benedetto, MJ Bevan Journal of immunology (Baltimore, Md.: 1950) 134 (6), 3994-4000, 1985 | 839 | 1985 |
| Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres S Walter, L Herrgen, O Schoor, G Jung, D Wernet, HJ Bühring, ... The Journal of Immunology 171 (10), 4974-4978, 2003 | 835 | 2003 |
| Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding HR Salih, HG Rammensee, A Steinle The Journal of Immunology 169 (8), 4098-4102, 2002 | 809 | 2002 |
| Autophagy promotes MHC class II presentation of peptides from intracellular source proteins J Dengjel, O Schoor, R Fischer, M Reich, M Kraus, M Müller, K Kreymborg, ... Proceedings of the National Academy of Sciences 102 (22), 7922-7927, 2005 | 786 | 2005 |
| Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). A Godkin, T Friede, M Davenport, S Stevanovic, A Willis, D Jewell, A Hill, ... International immunology 9 (6), 905-911, 1997 | 786 | 1997 |
| Human peripheral blood monuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro R Teufel, JP Carralot, B Scheel, J Probst, S Walter, G Jung, I Hoerr, ... Cellular and Molecular Life Sciences CMLS 62, 1755-1762, 2005 | 781 | 2005 |
| Actively personalized vaccination trial for newly diagnosed glioblastoma N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ... Nature 565 (7738), 240-245, 2019 | 741 | 2019 |
| The HLA-A* 6601 peptide motif: prediction by pocket structure and verification by peptide analysis FH Seeger, M Schirle, J Gatfield, D Arnold, W Keilholz, P Nickolaus, ... Immunogenetics 49, 571-576, 1999 | 721 | 1999 |
| Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia HR Salih, H Antropius, F Gieseke, SZ Lutz, L Kanz, HG Rammensee, ... Blood 102 (4), 1389-1396, 2003 | 689 | 2003 |
